HK1168086A1 - Improved method for manufacturing dipeptidyl peptidase-iv inhibitor and intermediate -iv - Google Patents

Improved method for manufacturing dipeptidyl peptidase-iv inhibitor and intermediate -iv

Info

Publication number
HK1168086A1
HK1168086A1 HK12108818.9A HK12108818A HK1168086A1 HK 1168086 A1 HK1168086 A1 HK 1168086A1 HK 12108818 A HK12108818 A HK 12108818A HK 1168086 A1 HK1168086 A1 HK 1168086A1
Authority
HK
Hong Kong
Prior art keywords
inhibitor
improved method
dipeptidyl peptidase
manufacturing
manufacturing dipeptidyl
Prior art date
Application number
HK12108818.9A
Other languages
English (en)
Chinese (zh)
Inventor
郭祐寧
金興載
閔鐘弼
尹泰鉉
沈賢珠
劉武姬
Original Assignee
東亞制藥株式會社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東亞制藥株式會社 filed Critical 東亞制藥株式會社
Publication of HK1168086A1 publication Critical patent/HK1168086A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D203/00Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/18Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK12108818.9A 2009-03-30 2012-09-10 Improved method for manufacturing dipeptidyl peptidase-iv inhibitor and intermediate -iv HK1168086A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090027106 2009-03-30
PCT/KR2010/001948 WO2010114292A2 (fr) 2009-03-30 2010-03-30 Procédé amélioré de fabrication d'inhibiteur de dipeptidyl peptidase-iv et d'intermédiaire

Publications (1)

Publication Number Publication Date
HK1168086A1 true HK1168086A1 (en) 2012-12-21

Family

ID=42828846

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12108818.9A HK1168086A1 (en) 2009-03-30 2012-09-10 Improved method for manufacturing dipeptidyl peptidase-iv inhibitor and intermediate -iv

Country Status (17)

Country Link
US (1) US8598347B2 (fr)
EP (2) EP2669266B1 (fr)
JP (1) JP5475864B2 (fr)
KR (1) KR101152898B1 (fr)
CN (1) CN102378752B (fr)
AU (1) AU2010232086B2 (fr)
BR (1) BRPI1014070B8 (fr)
CA (1) CA2756915C (fr)
ES (1) ES2571443T3 (fr)
HK (1) HK1168086A1 (fr)
HU (1) HUE029168T2 (fr)
IL (1) IL215289A (fr)
MX (1) MX2011010205A (fr)
NZ (1) NZ595543A (fr)
RU (1) RU2498976C9 (fr)
SG (1) SG174973A1 (fr)
WO (1) WO2010114292A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2800245C (fr) * 2009-03-30 2015-03-24 Dong-A Pharmaceutical Co., Ltd. Procede ameliore d'elaboration d'inhibiteur de dipeptidyl peptidase-iv et d'intermediaire
CN104257437B (zh) * 2014-10-20 2016-01-06 谢杨 一种动物脊髓损伤造模装置
KR101709127B1 (ko) 2015-06-16 2017-02-22 경동제약 주식회사 Dpp-iv 억제제의 제조를 위한 신규 중간체, 이의 제조방법 및 이를 이용한 dpp-iv 억제제의 제조방법
CN105017081B (zh) * 2015-07-08 2017-03-08 和鼎(南京)医药技术有限公司 一种西他列汀中间体的制备方法
WO2019241574A1 (fr) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Procédés pour abaisser la glycémie avec une composition pharmaceutique d'inhibiteur de la dipeptidylpeptidase-4
CN116554060A (zh) * 2023-05-23 2023-08-08 江苏八巨药业有限公司 一种Boc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781221B1 (fr) * 1998-07-17 2000-10-13 Lafon Labor Piperazinones substituees en alpha
KR20000065816A (ko) * 1999-04-09 2000-11-15 성재갑 파라 및/또는 메타-치환 시아노페닐알라닌 유도체의 새로운 합성방법
ES2257555T3 (es) 2001-06-20 2006-08-01 MERCK & CO., INC. Inhibidores de dipeptidilpeptidasa para el tratamiento de la diabetes.
UA74912C2 (en) * 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
ATE373660T1 (de) 2002-03-25 2007-10-15 Merck & Co Inc Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
CA2490818A1 (fr) 2002-07-15 2004-01-22 Merck & Co., Inc. Inhibiteurs de piperidino pyrimidine dipeptidyl peptidase utilises dans le traitement du diabete
ES2291680T3 (es) 2002-10-07 2008-03-01 MERCK & CO., INC. Antidiabeticos beta-amino heterociclicos inhibidores de la dipeptidil peptidasa.
US20060178370A1 (en) 2003-03-18 2006-08-10 Mark Bock Ketopiperazine derivatives as bradykinin antagonists
WO2004087650A2 (fr) 2003-03-27 2004-10-14 Merck & Co. Inc. Procede et intermediaires pour la preparation d'inhibiteurs d'amide d'acide beta-amino de dipeptidyle peptidase-iv
CA2533893A1 (fr) * 2003-07-31 2005-02-10 Merck & Co., Inc. Hexahydrodiazepinones utilises en tant qu'inhibiteurs de la dipeptidyl peptidase iv pour le traitement ou la prevention du diabete
WO2006098342A1 (fr) * 2005-03-16 2006-09-21 Astellas Pharma Inc. Composes de la piperazinyle
EP1702916A1 (fr) 2005-03-18 2006-09-20 Santhera Pharmaceuticals (Schweiz) GmbH Inhibiteurs de DPP-IV
WO2007063928A1 (fr) 2005-11-30 2007-06-07 Toray Industries, Inc. Nouveau derive non cyclique d’amine carboxamide et sel de celui-ci
US20090156465A1 (en) 2005-12-30 2009-06-18 Sattigeri Jitendra A Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
WO2008028662A1 (fr) 2006-09-07 2008-03-13 Santhera Pharmaceuticals (Schweiz) Ag N-[1-(3-amino-4-phenyl-butyryl)-4-hydroxy-pyrrolidin-2-ylmethyl}-propionamide et composés associés utilisés en tant qu'inhibiteurs dpp-iv pour le traitement du diabète sucré de type 2
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JP5148686B2 (ja) 2007-04-19 2013-02-20 ドン・ア・ファーム・カンパニー・リミテッド β−アミノ基を含むDPP−IV阻害剤、その製造方法及びそれを有効成分として含む糖尿または肥満予防及び治療用医薬組成物
KR100904426B1 (ko) 2007-09-11 2009-06-26 주식회사 하이닉스반도체 내부 전압 생성 회로

Also Published As

Publication number Publication date
RU2498976C2 (ru) 2013-11-20
MX2011010205A (es) 2011-10-17
KR101152898B1 (ko) 2012-06-05
US20120016126A1 (en) 2012-01-19
IL215289A (en) 2015-10-29
IL215289A0 (en) 2011-11-30
NZ595543A (en) 2013-05-31
WO2010114292A2 (fr) 2010-10-07
EP2669266B1 (fr) 2016-02-24
KR20100109493A (ko) 2010-10-08
RU2011141209A (ru) 2013-05-10
CN102378752B (zh) 2014-08-20
ES2571443T3 (es) 2016-05-25
US8598347B2 (en) 2013-12-03
EP2415754A4 (fr) 2012-08-22
JP5475864B2 (ja) 2014-04-16
EP2415754A2 (fr) 2012-02-08
BRPI1014070B8 (pt) 2021-05-25
CA2756915A1 (fr) 2010-10-07
SG174973A1 (en) 2011-11-28
BRPI1014070A2 (pt) 2016-04-12
RU2498976C9 (ru) 2014-02-27
EP2669266A1 (fr) 2013-12-04
HUE029168T2 (hu) 2017-02-28
JP2012522045A (ja) 2012-09-20
CA2756915C (fr) 2015-06-02
AU2010232086B2 (en) 2013-02-28
WO2010114292A3 (fr) 2011-01-20
BRPI1014070B1 (pt) 2020-10-20
AU2010232086A1 (en) 2011-11-03
CN102378752A (zh) 2012-03-14

Similar Documents

Publication Publication Date Title
GB0905140D0 (en) Method
IL209711A (en) Raw to developer and method of production
GB0902476D0 (en) Method
EP2480082A4 (fr) Aminopipéridines substituées utilisées en tant qu'inhibiteurs de la dipeptidyl peptidase-iv dans le cadre du traitement du diabète
HK1164795A1 (en) Laminate and method for producing same
ZA201106436B (en) Method for decontaminating surfaces
IL234436A (en) A method for preparing dipeptidyl peptide inhibitor and intermediate substance iv
EP2462943A4 (fr) Inhibiteur de dipeptidyle peptidase-4
EP2413941A4 (fr) Inhibiteurs de la rénine
EP2484719A4 (fr) Agent compatibilisant et son procédé de fabrication
HK1168086A1 (en) Improved method for manufacturing dipeptidyl peptidase-iv inhibitor and intermediate -iv
GB0901444D0 (en) Method
EP2261262A4 (fr) Procédé de fabrication de polyuronate
GB0903316D0 (en) Method
EP2648517A4 (fr) Hétérocycles tricycliques utiles comme inhibiteurs de la dipeptidyl peptidase iv
SI2251168T1 (sl) Postopek za izdelavo lesenih plošč
EP2467385A4 (fr) Inhibiteurs de rénine
EP2320434A4 (fr) Méthode de production de ferrites
IL213105A0 (en) Dipeptidyl peptidase iv inhibitors
GB0902034D0 (en) Method
GB0900560D0 (en) Method
PL2336380T3 (pl) Sposób i narzędzie do obróbki powierzchni
GB0904946D0 (en) Method
PL389931A1 (pl) Sposób modyfikacji drewna
GB0905332D0 (en) Method